Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Darbepoetin alfa 150micrograms/0.3ml inj pre-filled syringes
0901030J0AAAIAI
|
Darbepoetin alfa | Darbepoetin alfa | Nutrition and Blood | 6 |
|
Darbepoetin alfa 300micrograms/0.6ml inj pre-filled syringes
0901030J0AAAKAK
|
Darbepoetin alfa | Darbepoetin alfa | Nutrition and Blood | 6 |
|
Aranesp 130micrograms/0.65ml inj pre-filled syringes
0901030J0BBAVAV
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | 5 |
|
Aranesp SureClick 40micrograms/0.4ml inj pre-filled pens
0901030J0BBAPAP
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | 5 |
|
Darbepoetin alfa 100micrograms/0.5ml inj pre-filled syringes
0901030J0AAAGAG
|
Darbepoetin alfa | Darbepoetin alfa | Nutrition and Blood | 5 |
|
Darbepoetin alfa 500micrograms/1ml inj pf dispos dev
0901030J0AAAMAM
|
Darbepoetin alfa | Darbepoetin alfa | Nutrition and Blood | 5 |
|
Aranesp SureClick 60micrograms/0.3ml inj pre-filled pens
0901030J0BBAQAQ
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | 2 |
|
Aranesp 500micrograms/1ml inj pre-filled syringes
0901030J0BBALAL
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | 1 |
|
Darbepoetin alfa 130micrograms/0.65ml inj pfs
0901030J0AAAVAV
|
Darbepoetin alfa | Darbepoetin alfa | Nutrition and Blood | 1 |
|
Aranesp 15micrograms/0.375ml inj pre-filled syringes
0901030J0BBADAD
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Aranesp 300micrograms/0.6ml inj pre-filled syringes
0901030J0BBAKAK
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Aranesp SureClick 100micrograms/0.5ml inj pre-filled pens
0901030J0BBASAS
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Aranesp SureClick 130micrograms/0.65ml inj pre-filled pens
0901030J0BBAWAW
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Aranesp SureClick 150micrograms/0.3ml inj pre-filled pens
0901030J0BBATAT
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Aranesp SureClick 300micrograms/0.6ml inj pre-filled pens
0901030J0BBAUAU
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Aranesp SureClick 500micrograms/1ml inj pre-filled pens
0901030J0BBAMAM
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Aranesp SureClick 80micrograms/0.4ml inj pre-filled pens
0901030J0BBARAR
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Darbepoetin alfa 130micrograms/0.65ml inj pf dispos dev
0901030J0AAAWAW
|
Darbepoetin alfa | Darbepoetin alfa | Nutrition and Blood | No data available |
|
Darbepoetin alfa 15micrograms/0.375ml inj pfs
0901030J0AAADAD
|
Darbepoetin alfa | Darbepoetin alfa | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.